Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway-Reference-Cited by-同舟云学术

Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway

Published:2003-06-15 Issue:12 Volume:170 Page:6348-6354
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Pritchard Jane,Han Rui,Horst Noah,Cruikshank William W.,Smith Terry J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Determinants of autoimmune thyroid disease

2. Davies, T. F.. 1996. The pathogenesis of Graves’ disease. L. E. Braverman, and R. D. Utiger, eds. Werner and Ingbar’s The Thyroid 7th Ed.525. Lippincott-Raven, Philadelphia.

3. Update Thyroid-Associated Ophthalmopathy

4. Immunohistochemical and Ultrastructural Studies on the Exenterated Orbital Tissues of a Patient with Graves' Disease

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Hearing Dysfunction in Patients With Graves’ Disease and Thyroid Eye Disease Without or With Teprotumumab;The Journal of Clinical Endocrinology & Metabolism;2024-08-14

2. Trends in Teprotumumab Insurance Authorization and Socioeconomic Determinants of Teprotumumab Access;Journal of Endocrinology and Metabolism;2024-08

3. TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease;Current Opinion in Endocrinology, Diabetes & Obesity;2024-07-31

4. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

5. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05